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A 46‐year‐old female patient experienced severe pain in both lower limbs
following a traffic accident in 2008. The pain mainly presented in her
feet; she also experienced sensory impairment, convulsions, and exercise
function disorders. She was diagnosed with neuropathic pain, and no
medicine had any remarkable effect. Therefore, spinal cord stimulation
(SCS) was performed in October 2019. Her pain did not reduce after the
initial adoption of conventional SCS until the application of high
frequency SCS (HF‐SCS). At the 6‐month follow‐up, the pain in her
lower limbs was considerably reduced, lower limb motor function was
slightly improved, and muscle twitching in both feet disappeared.
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Introduction

Neuropathic pain is always intractable despite
different kinds of available medicines. Spinal
cord stimulation (SCS) has been used in the
treatment of neuropathic pain as a minimally
invasive, invertible therapeutic method with
implanted equipment and highly sophisticated
techniques for more than 50 years [1]. For
conventional low‐frequency SCS (LF‐SCS;
30–300 Hz), the patient needs to report coverage
of the pain position by stimulation‐evoked
paresthesia for pain relief [2, 3]. However, a
noteworthy feature of the high‐frequency (HF)
SCS (> 500 Hz, most often 10 kHz) is that it can
provide analgesic effects without the manifestation
of paresthesia or other abnormal sensations
Corresponding author: Yi Jin, E-mail: kimye@vip.163.com

along with the stimulation [4]. Traditional
LF‐SCS is ineffective in some patients with
neuropathic pain [5], especially those with
imperceptible stimulation‐evoked paresthesia
caused by physical sensory impairment.
However, HF‐SCS may be helpful and may
result from different mechanisms between
LF‐SCS and HF‐SCS. In addition, HF‐SCS may
also promote the motor function of the limbs.
Here, we report a neuralgia patient with
bilateral para‐anesthesia and twitching of both
the feet to achieve HF‐SCS.

2

Case report

The patient was a 46‐year‐old female who had
experienced pain, sensory denervation, partial
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motor disturbance, twitching of the bilateral feet,
and dysfunctions of excretion resulting from the
spinal conus injury caused by a fracture of L1
vertebral body in a car crash 12 years previously.
Although she had received timely surgical
treatment, those complications did not disappear.
The myodynamia of bilateral gastrocnemius was
grade 3. Achilles reflex was decreased. The
catheterization was continuous because of
dysuresia, and she had chronic, long‐standing
dyschezia. More importantly, she had severe
pain in both feet that negatively influenced her
ability to perform activities of daily living. Her
pain presented as a pinprick sensation that is
considered a symptom of neuropathic pain.
Sometimes, the pain score (visual analogue scale,
VAS) could reach 10. Oral medication (total
daily dose of tramadol was 200 mg for 11 years,
total daily dose of gabapentin was 2700 mg for
10 years), paravertebral nerve blockers (2 doses
of 0.125% ropivacaine combined with 40 mg of
methylprednisolone), or injections of sacral

Fig. 1
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canal steroids (a single dose of methylpredni‐
solone was 40 mg) was not able to alleviate her
pain effectively.
Therefore, SCS was performed to achieve pain
relief. The patient was unable to perceive stimuli
in the area of pain during the SCS procedure.
Therefore, the electrodes (PINS®, China) were
implanted into the thoracic epidural space (at
the level of T9–T11) as per the anatomical
definition (Fig. 1). The patient could experience
paresthesia of electrical stimulation in the thighs
and calves. During the first week of SCS
treatment, there was no reduction in pain for the
conventional LF‐SCS patterns with frequency
30–100 Hz. However, the application of 1 kHz
HF‐SCS in the patient produced an analgesic
effect after 3 days. Finally, follow‐up was
continued for 6 months, and her feet pain
reduced substantially; she discontinued oral
painkillers. Moreover, the twitching in her lower
limbs was reduced, and lower limb motor
function was slightly improved.

The radiography images showing the implant position of the spinal cord stimulation electrodes, and the internal

fixations for L1 vertebral body fracture and L4 spondylolisthesis.
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Discussion

The conventional LF‐SCS depends on the
patientʹs perception of electrical stimulation
[2, 3]. This patient could not report the stimula‐
tion‐evoked paresthesia due to loss of sensation
in her feet. Thus, we were unsure of the
effectiveness of conventional LF‐SCS in the
beginning. Then, the electrodes with both low‐
and high‐frequency stimulation parameters
were implanted. It was not surprising that the
traditional LF‐SCS did not relieve the feet pain
in the patient. However, HF‐SCS became an
option for achieving pain relief and later proved
effective. This may be because of the different
mechanisms of LF‐SCS and HF‐SCS.
It has been demonstrated that the analgesic
effect of conventional LF‐SCS may be related to
the activation of dorsal column collaterals
secondary to the induction of the release of
inhibitory neurotransmitters, notably γ‐amino‐
butyric acid (GABA), acetylcholine (ACH), and
serotonin (5‐HT) [6–10]. The LF‐SCS can cause
GABA release in the dorsal horn (DH), mainly
activating GABA‐B receptors and decreasing the
release of excitatory amino acids from the
hyperactivity of wide dynamic range (WDR)
neurons in the superficial laminae of the
corresponding DH [6, 11, 12]. In addition, the
investigators also used rat models of painful
neuropathy and confirmed that LF‐SCS induced
cholinergic neurons to release ACH in the DH
and activate M4 and M2 muscarinic type
receptors after nerve injury [8, 9]. Moreover, the
DH could be activated by orthodromic low‐
frequency stimulation, inducing descending
inhibition via the serotonergic and noradre‐
nergic pathways. The neuronal circuitry in the
brainstem (particularly in the rostroventro‐
medial medulla) may release 5‐HT and NE that
inhibit DH through dorsolateral funiculus [13].

The conventional LF‐SCS has a very close
relationship with the activation of the dorsal
columns (DCs).
HF‐SCS has been available for many years;
however, it has been reported rarely [14].
HF‐SCS is demonstrated to have superior
analgesia effects in a few clinical trials [15–17].
HF‐SCS involves the use of kilohertz tonic
stimulation without paresthesia that is superior
to low‐frequency tonic SCS in treating neuro‐
pathic pain. It was applied to DH in animal
models and in clinical trials that might provide
a local conduction block and effective pain
relief [18–20]. HF‐SCS would lead to the
generation of quickly reversible conduction
block along with several nodes of Ranvier via
the inactivation of sodium channels in several
animal models [19, 21]. However, recent simulation
models in silico displayed that conduction block
thresholds are almost beyond the clinical
amplitude range that matches with other
research results about an original augment in
action potential firing called the onset response
before HF‐SCS induced a conduction block. This
onset response has the ability to increase the
WDR activity and results in discomfort during
the first few moments of HF‐SCS in animal
models [22]. Instead, HF‐SCS treatment has
effectively alleviated pain in patients who have
not reported paresthesia or other subjective
perceptions [23]. These results suggested that
HF‐SCS‐induced analgesia may have no
connection with the activation or conduction
block of fibers in DCs. Therefore, more complex
and delicate analgesia mechanisms may be
involved. A recent study suggested that HF‐SCS
can attenuate extracellular regulated protein
kinase (ERK), c‐Jun N‐terminal kinase (JNK),
and p38 activation in the spinal DH and in the
dorsal root ganglia, providing effective treatment
for spared nerve injury (SNI)‐induced neuropathic
Journal of Neurorestoratology
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pain in rats [24]. Other studies have shown that
the superficial neurons of the DH might be
directly inhibited by effective HF‐SCS [25]. This
may be a possible reason why the patient
achieved pain relief with HF‐SCS.
In this patient, lower limb pain was
considerably reduced after HF‐SCS that also
helped in the regulation of muscle movements.
Recent studies on the use of HF‐SCS in
respiratory muscles have shown that HF‐SCS
induced considerable activation of the inspira‐
tory or expiratory muscle via very low stimulus
currents [26, 27]. Nonetheless, it remains unclear
what mechanism of HF‐SCS regulates limb
muscles functions.
Currently, it is suggested that HF‐SCS be
applied with low amplitude (below the pares‐
thesia threshold) to prevent an uncomfortable
experience [28]. Therefore, if the pain is
associated with loss of sensation and is not
relieved with conventional low‐frequency
stimulation, HF‐SCS treatment may be a good
alternative.

4

Conclusion

In conclusion, we would like to share this case
about the experience of SCS for severe refractory
neuropathic pain with sensory impairment.
HF‐SCS may be a reasonable choice in special
patients such as the present patient.
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